Molina-Infante, J <br/><br/>
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  May 2010 
 - 1077-84 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2010.04274.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amoxicillin--therapeutic use<br/>Anti-Bacterial Agents--therapeutic use<br/>Anti-Ulcer Agents--therapeutic use<br/>Clarithromycin--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori--drug effects<br/>Humans<br/>Levofloxacin<br/>Male<br/>Metronidazole--therapeutic use<br/>Middle Aged<br/>Ofloxacin--therapeutic use<br/>Omeprazole--therapeutic use<br/>Treatment Outcome<br/>Young Adult